EVOME MEDICAL TECHNOLOGIES INC. Quarterly Return On Equity in % from Q1 2021 to Q4 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Evome Medical Technologies Inc. quarterly/annual Return On Equity history and growth rate from Q1 2021 to Q4 2023.
  • Evome Medical Technologies Inc. Return On Equity for the quarter ending December 31, 2023 was -117 %, a 28.7% decline year-over-year.
  • Evome Medical Technologies Inc. annual Return On Equity for 2023 was -117 %.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q4 2023 -117 -26.1 -28.7% Oct 1, 2023 Dec 31, 2023
Q3 2023 -8.17 +92.5 +91.9% Jul 1, 2023 Sep 30, 2023
Q2 2023 -92.9 -45.3 -95% Apr 1, 2023 Jun 30, 2023
Q1 2023 -96 -61.6 -179% Jan 1, 2023 Mar 31, 2023
Q4 2022 -91.2 -38 -71.6% Sep 1, 2022 Nov 30, 2022
Q3 2022 -101 -59.3 -143% Jul 1, 2022 Sep 30, 2022
Q2 2022 -47.7 -12.6 -35.9% Apr 1, 2022 Jun 30, 2022
Q1 2022 -34.4 -2.55 -8.01% Jan 1, 2022 Mar 31, 2022
Q4 2021 -53.1 Sep 1, 2021 Nov 30, 2021
Q3 2021 -41.4 Jun 1, 2021 Aug 31, 2021
Q2 2021 -35.1 Mar 1, 2021 May 31, 2021
Q1 2021 -31.8 Dec 1, 2020 Feb 28, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.